D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 41 Citations 12,375 93 World Ranking 3551 National Ranking 1643

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Virus

Vivien Béziat mostly deals with Immunology, Virus, NK Cell Lectin-Like Receptor Subfamily C, Interleukin 12 and Immunity. Immune system is the focus of his Immunology research. His NK Cell Lectin-Like Receptor Subfamily C research focuses on subjects like Human leukocyte antigen, which are linked to Human cytomegalovirus.

His Interleukin 12 study combines topics in areas such as Interleukin 21 and Cell biology. The Immunity study combines topics in areas such as Pneumonia, Young adult, Phenocopy, Asymptomatic and Disease. His studies in Asymptomatic integrate themes in fields like Interferon, Interferon type I, Autoantibody, Case-control study and Allele.

His most cited work include:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Immunology, Interleukin 21, Interleukin 12, Lymphokine-activated killer cell and Genetics. Vivien Béziat interconnects Receptor and Haematopoiesis in the investigation of issues within Immunology. His work deals with themes such as Natural killer cell, Interferon gamma and Cell biology, which intersect with Interleukin 12.

His research in Lymphokine-activated killer cell intersects with topics in Janus kinase 3, Cell therapy and Cancer immunotherapy. The Virus study combines topics in areas such as Interferon, Antibody and Pneumonia. As a member of one scientific family, Vivien Béziat mostly works in the field of Interferon, focusing on Young adult and, on occasion, Asymptomatic.

He most often published in these fields:

  • Immunology (123.53%)
  • Interleukin 21 (44.54%)
  • Interleukin 12 (43.70%)

What were the highlights of his more recent work (between 2019-2021)?

  • Immunology (123.53%)
  • Immunity (31.09%)
  • Pneumonia (22.69%)

In recent papers he was focusing on the following fields of study:

Vivien Béziat spends much of his time researching Immunology, Immunity, Pneumonia, Asymptomatic and Loss function. His work carried out in the field of Immunology brings together such families of science as Dominant-Negative Mutation, Cell, Allele and Phenocopy. His Allele study integrates concerns from other disciplines, such as Young adult and Interferon, Interferon type I.

His Phenocopy research is multidisciplinary, incorporating elements of Immunoglobulin G, Autoantibody, Disease and Case-control study. In his study, Adverse effect and Vaccination is inextricably linked to Virus, which falls within the broad field of Pneumonia. Vivien Béziat has included themes like Tropism, Recurrent Respiratory Papillomatosis, Human genetics and Pathogenesis in his Asymptomatic study.

Between 2019 and 2021, his most popular works were:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Genetics

His primary areas of study are Immunology, Immunity, Allele, Asymptomatic and Phenocopy. His Immunity research entails a greater understanding of Genetics. The study incorporates disciplines such as Mutant, Dominant-Negative Mutation, Receptor, Transmembrane domain and Glycoprotein 130 in addition to Allele.

His studies in Asymptomatic integrate themes in fields like Pneumonia, Young adult and Interferon, Interferon type I, Virus. His Phenocopy research is multidisciplinary, incorporating perspectives in Loss function, Autoantibody, Immunoglobulin G, Case-control study and Disease. His Loss function research includes elements of Frameshift mutation, Negative selection and Mendelian inheritance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis.
Science (2020)

548 Citations

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen.
Science (2020)

458 Citations

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Heinrich Schlums;Frank M Cichocki;Frank M Cichocki;Bianca Tesi;Jakob Theorell.
Immunity (2015)

399 Citations

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRS

Vivien Béziat;Lisa L. Liu;Jenny-Ann Malmberg;Martin A. Ivarsson.
Blood (2013)

361 Citations

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon.
European Journal of Immunology (2012)

280 Citations

Unconventional Repertoire Profile Is Imprinted during Acute Chikungunya Infection for Natural Killer Cells Polarization toward Cytotoxicity

Caroline Petitdemange;Pierre Becquart;Nadia Wauquier;Vivien Béziat.
PLOS Pathogens (2011)

259 Citations

Human NK cells display major phenotypic and functional changes over the life span.

Magali Le Garff-Tavernier;Magali Le Garff-Tavernier;Vivien Béziat;Vivien Béziat;Julie Decocq;Julie Decocq;Virginie Siguret.
Aging Cell (2010)

235 Citations

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs

Vivien Béziat;Vivien Béziat;Benjamin Descours;Benjamin Descours;Christophe Parizot;Patrice Debré;Patrice Debré.
PLOS ONE (2010)

200 Citations

Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells

Nicole Marquardt;Vivien Béziat;Sanna Nyström;Julia Hengst.
Journal of Immunology (2015)

196 Citations

Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C- Deficient Humans

Lisa L. Liu;Johannes Landskron;Eivind H. Ask;Eivind H. Ask;Monika Enqvist.
Cell Reports (2016)

158 Citations

Best Scientists Citing Vivien Béziat

Karl-Johan Malmberg

Karl-Johan Malmberg

Oslo University Hospital

Publications: 60

Laurent Abel

Laurent Abel

Inserm : Institut national de la santé et de la recherche médicale

Publications: 58

Jean-Laurent Casanova

Jean-Laurent Casanova

Rockefeller University

Publications: 51

Yenan T. Bryceson

Yenan T. Bryceson

University of Bergen

Publications: 46

Anne Puel

Anne Puel

Rockefeller University

Publications: 44

Jeffrey S. Miller

Jeffrey S. Miller

University of Minnesota

Publications: 39

Stuart G. Tangye

Stuart G. Tangye

Garvan Institute of Medical Research

Publications: 38

Christian Münz

Christian Münz

University of Zurich

Publications: 36

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 33

Hans-Gustaf Ljunggren

Hans-Gustaf Ljunggren

Karolinska Institute

Publications: 33

Shen-Ying Zhang

Shen-Ying Zhang

Rockefeller University

Publications: 33

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 31

Joseph C. Sun

Joseph C. Sun

Memorial Sloan Kettering Cancer Center

Publications: 28

Miguel López-Botet

Miguel López-Botet

Pompeu Fabra University

Publications: 27

Alessandro Moretta

Alessandro Moretta

University of Genoa

Publications: 27

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.